Related Articles by Review for PMID: 32644454

Year	Number of Results
1993	1
1994	1
1995	1
1997	2
2001	1
2006	1
2012	1
2014	2
2015	1
2016	3
2017	1
2018	2
2019	3
2020	3
2021	2
2022	1
2023	2
2024	2
2025	1

1

Fecek C, Emmady PD. Fecek C, et al. 2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32644454 Free Books & Documents.

2

Non-Union After Multiple Lumbar Fusion Surgeries in a Patient With Facioscapulohumeral Muscular Dystrophy: A Case Report and Review of the Literature.

Mehta AV, Maurer R, Reiter GT. Mehta AV, et al. World Neurosurg. 2020 Jul;139:281-285. doi: 10.1016/j.wneu.2020.04.030. Epub 2020 Apr 18. World Neurosurg. 2020. PMID: 32311553 Review.

3

Genetic Approaches for the Treatment of Facioscapulohumeral Muscular Dystrophy.

Lim KRQ, Yokota T. Lim KRQ, et al. Front Pharmacol. 2021 Mar 12;12:642858. doi: 10.3389/fphar.2021.642858. eCollection 2021. Front Pharmacol. 2021. PMID: 33776777 Free PMC article. Review.

4

Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011.

Attarian S, Salort-Campana E, Nguyen K, Behin A, Andoni Urtizberea J. Attarian S, et al. Rev Neurol (Paris). 2012 Dec;168(12):910-8. doi: 10.1016/j.neurol.2011.11.008. Epub 2012 Apr 30. Rev Neurol (Paris). 2012. PMID: 22551571 Free article. Review.

5

Management strategies in facioscapulohumeral muscular dystrophy.

Lu J, Yao Z, Yang Y, Zhang C, Zhang J, Zhang Y. Lu J, et al. Intractable Rare Dis Res. 2019 Feb;8(1):9-13. doi: 10.5582/irdr.2019.01016. Intractable Rare Dis Res. 2019. PMID: 30881851 Free PMC article. Review.

6

Oligonucleotide Therapies for Facioscapulohumeral Muscular Dystrophy: Current Preclinical Landscape.

Beck SL, Yokota T. Beck SL, et al. Int J Mol Sci. 2024 Aug 21;25(16):9065. doi: 10.3390/ijms25169065. Int J Mol Sci. 2024. PMID: 39201751 Free PMC article. Review.

7

French National Protocol for diagnosis and care of facioscapulohumeral muscular dystrophy (FSHD).

Attarian S, Beloribi-Djefaflia S, Bernard R, Nguyen K, Cances C, Gavazza C, Echaniz-Laguna A, Espil C, Evangelista T, Feasson L, Audic F, Zagorda B, Milhe De Bovis V, Stojkovic T, Sole G, Salort-Campana E, Sacconi S. Attarian S, et al. J Neurol. 2024 Sep;271(9):5778-5803. doi: 10.1007/s00415-024-12538-3. Epub 2024 Jul 2. J Neurol. 2024. PMID: 38955828 Review.

8

Molecular genetics of facioscapulohumeral muscular dystrophy (FSHD).

Fisher J, Upadhyaya M. Fisher J, et al. Neuromuscul Disord. 1997 Jan;7(1):55-62. doi: 10.1016/s0960-8966(96)00400-2. Neuromuscul Disord. 1997. PMID: 9132141 Review.

9

Facioscapulohumeral muscular dystrophy.

Tawil R, Van Der Maarel SM. Tawil R, et al. Muscle Nerve. 2006 Jul;34(1):1-15. doi: 10.1002/mus.20522. Muscle Nerve. 2006. PMID: 16508966 Review.

10

Facioscapulohumeral muscular dystrophy in early childhood.

Brouwer OF, Padberg GW, Wijmenga C, Frants RR. Brouwer OF, et al. Arch Neurol. 1994 Apr;51(4):387-94. doi: 10.1001/archneur.1994.00540160085011. Arch Neurol. 1994. PMID: 8155016 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 32644454

29 results

Results by year